DIalysis Symptom COntrol-Restless Legs Syndrome Trial
common.study.values.description
“DIalysis Symptom COntrol-Restless Legs Syndrome Trial”
The DISCO-RLS Trial is a randomized controlled trial to determine the safety and efficacy of pharmacologic therapy (ropinirole versus placebo and gabapentin versus placebo) for the treatment of Restless Legs Syndrome in patients with End Stage Renal Disease requiring hemodialysis.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-yes
Drug - Gabapentin
100 mg capsule
Drug - Ropinirole
0.50 mg capsule
Drug - Placebo Gabapentin
Placebo capsule
Drug - Placebo Ropinirole
Placebo capsule
participant.views.study.view.additional
participant.views.study.view.scientific-title
DIalysis Symptom COntrol-Restless Legs Syndrome Trial (DISCO-RLS Trial): A Randomized Controlled Trial
common.study.values.clinical-trial-id
NCT03806530
participant.views.study.view.id
dPNgla
